Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.

about

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.

Item

http://www.wikidata.org/entity/Q54981113

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.

@en

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.

@nl

type

Item

label

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.

@en

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.

@nl

prefLabel

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.

@en

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.

@nl

P1476

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma.

@en

P2093

Christine Damm-Welk

http://www.w3.org/2001/XMLSchema#string

Fabian Knörr

http://www.w3.org/2001/XMLSchema#string

Serena Stadler

http://www.w3.org/2001/XMLSchema#string

Vijay Kumar Singh

http://www.w3.org/2001/XMLSchema#string

Wilhelm Woessmann

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-10-induced MARCH1 mediates intracellular sequestration of MHC class II in monocytes

Autoantibody Production in Cancer--The Humoral Immune Response toward Autologous Antigens in Cancer Patients

A brief history of T cell help to B cells

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study.

ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system

Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.

Induction of resident memory T cells enhances the efficacy of cancer vaccine

Hematopoietic stem cell transplantation for refractory or recurrent non-Hodgkin lymphoma in children and adolescents.

P31

scholarly article

P356

10.3390/CANCERS10040114

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29642597

http://www.w3.org/2001/XMLSchema#string

P932

5923369

http://www.w3.org/2001/XMLSchema#string